Skip to content

Spanish Registry of Mohs Surgery

Spanish Registry of Mohs Surgery [Registro Español de Cirugía de Mohs]

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02310503
Acronym
REGESMOHS
Enrollment
6000
Registered
2014-12-08
Start date
2013-07-01
Completion date
2020-02-29
Last updated
2020-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous, Melanoma, Neoplasms, Adnexal and Skin Appendage, Skin Neoplasms

Keywords

Mohs Surgery

Brief summary

REGESMOHS (Registro Español de cirugía de Mohs) aims at describing effectiveness of Mohs surgery, and patient, tumor and technique factors related to adverse events and tumor recurrence. REGESMOHS is a prospective cohort, including all patients considered for Mohs surgery in participating centers. All consecutive patients are included. The only exclusion criteria are being under 18-years-old or legally incompetent. Pre-planned follow-up is as required by common clinical practice, but at least once a year for the study period.

Interventions

PROCEDUREMohs surgery

A surgical technique used primarily in the treatment of skin neoplasms, especially basal cell or squamous cell carcinoma of the skin. This procedure is a microscopically controlled excision of cutaneous tumors either after fixation in vivo or after freezing the tissue. Serial examinations of fresh tissue specimens are most frequently done.

Sponsors

Roche Pharma AG
CollaboratorINDUSTRY
Fundación Academia Española de Dermatología
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All consecutive patients considered for Mohs surgery

Exclusion criteria

* Under 18 years-old * Legally incompetent

Design outcomes

Primary

MeasureTime frame
Tumor recurrence6 years

Secondary

MeasureTime frameDescription
Short term outcomes1 monthBleeding, infection, abnormal scar, necrosis
Use of resourcesDuring surgeryNeed for admission, type of anesthesia, number of surgical steps, participating doctors,time in surgery room.
Impairments of body function and structure6 yearspresence of: abnormal scar, ectropion, nostril alteration, oral sphincter incompetence,other

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026